JPWO2025058005A1 - - Google Patents

Info

Publication number
JPWO2025058005A1
JPWO2025058005A1 JP2025545723A JP2025545723A JPWO2025058005A1 JP WO2025058005 A1 JPWO2025058005 A1 JP WO2025058005A1 JP 2025545723 A JP2025545723 A JP 2025545723A JP 2025545723 A JP2025545723 A JP 2025545723A JP WO2025058005 A1 JPWO2025058005 A1 JP WO2025058005A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025545723A
Other languages
Japanese (ja)
Other versions
JPWO2025058005A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2025058005A1 publication Critical patent/JPWO2025058005A1/ja
Publication of JPWO2025058005A5 publication Critical patent/JPWO2025058005A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2025545723A 2023-09-15 2024-09-12 Pending JPWO2025058005A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023150265 2023-09-15
PCT/JP2024/032644 WO2025058005A1 (ja) 2023-09-15 2024-09-12 筋萎縮性側索硬化症(als)と関連するバイオマーカー

Publications (2)

Publication Number Publication Date
JPWO2025058005A1 true JPWO2025058005A1 (https=) 2025-03-20
JPWO2025058005A5 JPWO2025058005A5 (https=) 2026-01-28

Family

ID=95021397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025545723A Pending JPWO2025058005A1 (https=) 2023-09-15 2024-09-12

Country Status (2)

Country Link
JP (1) JPWO2025058005A1 (https=)
WO (1) WO2025058005A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013511732A (ja) * 2009-11-24 2013-04-04 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション 神経障害の診断、診断補助および/またはその進行のモニタリングのための方法、キットおよび試薬
JP2013522589A (ja) * 2010-03-10 2013-06-13 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド Alsの早期診断およびals進行のための細胞性血液マーカー
JP2021523375A (ja) * 2018-05-10 2021-09-02 ザ・メソジスト・ホスピタル 疾病の予後と管理のための方法
WO2023044331A1 (en) * 2021-09-16 2023-03-23 The Methodist Hospital Serum immune-based biomarkers for use in als therapy

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013511732A (ja) * 2009-11-24 2013-04-04 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション 神経障害の診断、診断補助および/またはその進行のモニタリングのための方法、キットおよび試薬
JP2013522589A (ja) * 2010-03-10 2013-06-13 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド Alsの早期診断およびals進行のための細胞性血液マーカー
JP2021523375A (ja) * 2018-05-10 2021-09-02 ザ・メソジスト・ホスピタル 疾病の予後と管理のための方法
WO2023044331A1 (en) * 2021-09-16 2023-03-23 The Methodist Hospital Serum immune-based biomarkers for use in als therapy

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JIAJIA FU: "The role of Th17 cells/Il-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A", JOURNAL OF NEUROINFLAMMATION, vol. 19, 98, JPN6024041255, 2022, pages 1 - 12, ISSN: 0005755130 *
JUNJUE CHEN: "Interleukin-17A: The key cytokine in neurodegenerative diseases", FRONT. AGING NEUROSCI., vol. vol.12, article.566922, JPN6024041256, pages 1 - 13, ISSN: 0005755131 *
MENGMENG JIN: "Interleukin-17 and Th17 lymphocytes directly impair motoneuron survival of wildtype and FUS-ALS muta", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 22, 8042, JPN6024041253, 27 July 2021 (2021-07-27), pages 1 - 15, ISSN: 0005755128 *
MILAN FIALA: "IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients", JPURNAL OF NEUROINFLAMMATION, vol. 7, 76, JPN6024041254, 2010, pages 1 - 14, ISSN: 0005755129 *

Also Published As

Publication number Publication date
WO2025058005A1 (ja) 2025-03-20

Similar Documents

Publication Publication Date Title
JP2023181255A5 (https=)
JPWO2025058005A1 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BY13161U (https=)
BY13158U (https=)
CN307048038S (https=)
CN307047016S (https=)
CN307046062S (https=)
CN307048163S (https=)
CN307046007S (https=)
CN307045972S (https=)
CN307044971S (https=)
CN307044897S (https=)
CN307048459S (https=)
BY13168U (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13152U (https=)
BY13160U (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251121

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20251121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251216

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260413

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260421